O.C.G.A.
O.C.G.A. § 31-51-10 (2019)
Sunset
✓ O.C.G.A. (archive.org 2024 item): print volumes of 2004-2024, per-volume vintage; older volumes partly replaced by 2019 Release 73 text; no 2025 or 2026 Acts
Code text and O.C.G.A. statutory annotations on this page reflect the 2019 Official Code of Georgia Annotated (Public.Resource.Org Release 73, 2019-08-21; public domain per Georgia v. Public.Resource.Org, 2020). The Syfert case-law annotations in Notes of Decisions, below, are current.
Find cases:
SyfertCases citing this section
GA-LEGlegis.ga.gov (official)
JustiaJustia
CornellLII Search
CasesGoogle Scholar
This chapter shall stand repealed on July 1, 2020.
History
Code 1981, § 31-51-10, enacted by Ga. L. 2015, p. 49, § 4-1/HB 1.
CHAPTER 52 TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES Sec.
Sec. Short title. Legislative findings. Definitions. Eligibility criteria. Written informed consent. Manufacturers permitted to make investigational drugs, biological products, or devices available. Coverage under health benefit
plan permitted but not required.